Dose modification for safe treatment of a compound complex heterozygous DPYD variant carrier with 5-fluorouracil.
Saved in:
| Title: | Dose modification for safe treatment of a compound complex heterozygous DPYD variant carrier with 5-fluorouracil. |
|---|---|
| Authors: | Shrestha S; Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN 55905 USA., Tapper EE; Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN 55905 USA., Trogstad-Isaacson CS; Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN 55905 USA., Hobday TJ; Mayo Clinic College of Medicine, Rochester, MN 55905 USA.; Department of Medical Oncology, Mayo Clinic, Rochester, MN 55905 USA., Offer SM; Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN 55905 USA.; Mayo Clinic College of Medicine, Rochester, MN 55905 USA.; Mayo Clinic Cancer Center, Rochester, MN 55905 USA., Diasio RB; Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN 55905 USA.; Mayo Clinic College of Medicine, Rochester, MN 55905 USA.; Mayo Clinic Cancer Center, Rochester, MN 55905 USA. |
| Source: | JCO precision oncology [JCO Precis Oncol] 2018; Vol. 2. Date of Electronic Publication: 2018 Oct 03. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 101705370 Publication Model: Print-Electronic Cited Medium: Print ISSN: 2473-4284 (Print) Linking ISSN: 24734284 NLM ISO Abbreviation: JCO Precis Oncol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
